azacitidine has been researched along with Disease Models, Animal in 119 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.36) | 18.7374 |
1990's | 5 (4.20) | 18.2507 |
2000's | 18 (15.13) | 29.6817 |
2010's | 78 (65.55) | 24.3611 |
2020's | 14 (11.76) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Fu, T; Jing, Y; Li, G; Li, J; Liu, Y; Lv, Z; Shao, C; Wang, Z; Zhao, Y | 1 |
Baek, JM; Bin, BH; Brito, S; Chae, S; Choi, MA; Heo, H; In, KR; Jang, D; Jo, H; Kang, MA; Kim, DO; Kim, JR; Kim, ST; Lee, JS; Lee, MG; Park, H | 1 |
Bouvet, M; Han, Q; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kimura, H; Kuchipudi, S; Miwa, S; Oshiro, H; Singh, SR; Sugisawa, N; Tan, Y; Tsuchiya, H; Yamamoto, J; Yamamoto, N | 1 |
Chen, N; Cheng, L; Dai, L; Deng, H; Dong, Z; Fang, C; Fu, J; Ji, Y; Li, J; Liu, Y; Shi, G; Su, X; Wang, H; Wang, W; Yang, Y; Yu, Y; Zhang, H; Zhang, S | 1 |
Boghaert, ER; Cojocari, D; Jin, S; Leverson, JD; Phillips, DC; Popovic, R; Purkal, JJ; Solomon, LR; Talaty, NN; Xiao, Y | 1 |
Battafarano, RJ; Baylin, SB; Brahmer, JR; Brock, MV; Broderick, SR; Bush, EL; Cai, Y; Cattaneo, SM; Cui, Y; Day, CP; Easwaran, H; Forde, PM; Housseau, F; Huang, P; Hulbert, A; Jiao, X; Juergens, RA; Kim, K; Kim, YJ; Kong, X; Lee, B; Li, H; Li, S; Lu, Z; Margolick, JB; Mei, Y; Nelkin, BD; Pardoll, DM; Riemer, JB; Rodgers, K; Rudin, CM; Shen, L; Tao, Y; Topper, MJ; Vaz, M; Wang, KK; Wang, Y; Wrangle, J; Xia, L; Xie, W; Yang, SC; Yen, RC; Zahnow, CA; Zhang, B; Zhang, H; Zhang, W; Zou, J | 1 |
Huang, F; Jiang, C; Jin, N; Li, C; Li, X; Liu, Q; Qin, Y; Zhang, C; Zhang, Y; Zhao, Y; Zhou, C | 1 |
Arrate, M; Azab, M; Boyd, K; Fuller, L; Gorska, AE; Keer, H; Oganesian, A; Ramsey, HE; Savona, MR | 1 |
Diamond, DJ; Ebelt, ND; Johnson, BL; Manuel, ER; Zuniga, E | 1 |
Adams, FF; Alwie, Y; Gabdoulline, R; Ganser, A; Gupta, C; Heckl, D; Heuser, M; Humphries, RK; Imren, S; Jyotsana, N; Kattre, N; Kloos, A; Mintzas, K; Schambach, A; Scherr, M; Schottmann, R; Schwarzer, A; Thol, F; Winckler, L | 1 |
Carraway, H; Durkin, L; Grabowski, D; Gu, X; Hamilton, B; Hasipek, M; Hong, C; Hsi, ED; Jha, BK; Maciejewski, J; Patel, B; Radivoyevitch, T; Sakre, N; Saunthararajah, Y; Schuerger, C; Sobecks, R; Tohme, R; Tomlinson, B; Zidan, AM | 1 |
Bachmaier, G; Berg, JL; Berghold, A; Geissler, K; Hatzl, S; Hoefler, G; Klymiuk, I; Mayer, MC; Perfler, B; Pichler, M; Pregartner, G; Reinisch, A; Sill, H; Strobl, H; Tierling, S; Uhl, B; Wölfler, A; Wurm, S; Zebisch, A | 1 |
Bassermann, F; Dahl, S; Haas, T; Heidegger, S; Poeck, H; Wintges, A | 1 |
Fang, F; Nephew, KP; Ozes, A; Wang, W | 1 |
Chen, Y; Huang, Z; Li, R; Li, Z; Liang, X; Lin, T; Liu, S; Ma, J; Shi, W; Tan, X; Wang, W; Ye, Z; Yu, C; Zhang, B; Zhang, H; Zhang, L; Zhang, Q; Zhao, X | 1 |
Arend, RC; Buchsbaum, DJ; Forero, A; Katre, A; Londoño, A; Meza-Perez, S; Norian, LA; Peabody, JE; Randall, TD; Smith, HJ; Straughn, JM; Turner, TB | 1 |
Ming, F; Sun, Q | 1 |
Chen, M; Dong, L; Feng, K; Han, W; Jia, H; Li, X; Liu, L; Liu, Y; Mei, Q; Nie, J; Shi, L; Zhang, Y | 1 |
Chen, JK; Ding, HF; Dong, Z; Fan, G; Guo, C; Huang, S; Pei, L; Shi, H; Wei, Q; Xiao, X | 1 |
Cao, J; Chen, P; Chen, Y; He, SD; He, ZH; Liu, D; Ye, JR; Zeng, HH | 1 |
Bachman, KE; Baylin, SB; Bhargava, V; Chiappinelli, KB; Cowley, GS; Hung, CF; Li, H; Lim, M; Mathios, D; Murphy, LM; Shih, IM; Stone, ML; Strick, R; Strissel, PL; Topper, MJ; Travers, ME; Wang, TL; Wiehagen, KR; Zahnow, CA | 1 |
Bushell, MD; Godfrey, JD; Morton, JP; Sansom, OJ; Wilczynska, A | 1 |
Choi, DH; Choi, IA; Kim, HY; Lee, CS; Lee, J | 1 |
Bickerton, S; Fahmy, TM; Kong, P; Li, H; Li, Y; Moulton, VR; Sharabi, A; Tsokos, GC; Tsokos, MG | 1 |
Anastasiadou, E; Avigan, D; Cole, L; Ephraim, A; Ghiasuddin, H; Jain, S; Kufe, D; Leaf, RK; Liegel, J; McMasters, M; Molldrem, JJ; Nahas, MR; Orr, S; Pyzer, AR; Rahimian, M; Rosenblatt, J; Sergeeva, A; Slack, F; Stroopinsky, D; Washington, A; Weinstock, M | 1 |
Balog, A; Block, JA; Bukiej, AA; Glant, TT; Jolly, M; Kovács, L; Markovics, A; Mikecz, K; Ocskó, T; Rauch, TA; Ruthberg, AD; Tóth, DM; Vida, A | 1 |
Bachman, KE; Baylin, SB; Brown, SM; Casero, RA; Dunworth, M; Foley, JR; Holbert, CE; Stone, ML; Travers, M; Wiehagen, KR; Zahnow, CA | 1 |
Chen, G; Chen, H; Dong, Z; Liu, H; Liu, Y; Ren, S; Sun, L; Tang, L; Xia, M; Zhang, L; Zhu, J | 1 |
Deng, X; Hu, Z; Li, X; Liu, Z; Zhou, Y | 1 |
Barak, S; Darcq, E; Levine, A; Ron, D; Warnault, V | 1 |
Dong, Y; Huang, H; Li, Q; Ning, Y; Sun, Q; Xu, W; Zhang, W | 1 |
Mori, A; Niwa, T; Tatematsu, M; Toyoda, T; Tsukamoto, T; Ushijima, T | 1 |
Cai, X; Chen, K; Chen, Q; Huang, A; Li, S; Nie, D; Quan, H; Shan, X; Tang, N; Zhou, F; Zhou, Z | 1 |
Katiyar, SK; Prasad, R | 1 |
Richards, KL; Small, GW; Smallwood, TL; Suter, SE | 1 |
Bolyard, C; Chiocca, EA; Fernandez, S; Haseley, A; Kasai, K; Kaur, B; Lehman, A; Meisen, H; Mo, X; Okemoto, K; Wagner, B; Wehr, A | 1 |
Chen, P; Chen, Y; He, Z; Peng, H; Zeng, H; Zhang, H; Zhang, Y | 1 |
Jiang, Z; Kuo, PY; Leshchenko, VV; Parekh, S; Thirukonda, VK | 1 |
Barankiewicz, J; Bednarek, W; Boon, L; Gabrysiak, M; Golab, J; Hamblin, MR; Mroz, P; Muchowicz, A; Rygiel, T; Wachowska, M | 1 |
Chen, L; He, QM; Jiang, N; Jiang, W; Li, YQ; Liu, N; Ma, J; Sun, Y; Xu, YF | 1 |
Bendtzen, K; Coco, M; Di Marco, R; Di Rosa, M; Fagone, P; Magro, G; Malaguarnera, L; Mammana, S; Mangano, K; Meroni, PL; Nicoletti, F; Quattrocchi, C | 1 |
De Vita, S; Ebert, BL; Garcia, M; Gavillet, M; Gerbaulet, A; Levine, RL; Mullally, A; Roers, A; Schneider, RK; Williams, DA; Wood, J | 1 |
De Bruyne, E; De Raeve, H; De Smedt, E; Lemaire, M; Maes, K; McClue, S; Menu, E; Van Valckenborgh, E; Vanderkerken, K | 1 |
Dunn, J; Fan, Y; Hoffman, R; Jang, I; Jjingo, D; Jo, H; Jordan, IK; Kim, CW; Kim, D; Kim, S; Pan, C; Qiu, H; Son, DJ | 1 |
Baylin, SB; Beaty, R; Bunz, F; Cui, Y; Hausheer, F; Issa, JP; Zahnow, C | 1 |
Dawn, B; Elias, HK; Malik, AB; Rajasingh, J; Rajasingh, S; Simpson, AD; Sundivakkam, PK; Thangavel, J; Vogel, SM; Xuan, YT | 1 |
Campbell, RR; Dang, D; Ono, K; Schmidt, BL; Viet, CT; Ye, Y | 1 |
Cao, JL; Peng, YN; Tang, LH; Wang, Y; Yan, M; Yu, LN; Zhou, XL | 1 |
Han, J; Sui, N; Zhang, JJ | 1 |
Ahn, JS; Cho, JH; Choi, JY; Kim, CD; Kim, KH; Kim, YL; Lee, JH; Oh, EJ; Oh, SH; Park, SH; Ryu, HM | 1 |
Agrawal, R; Gomez-Pinilla, F; Tyagi, E; Ying, Z; Zhuang, Y | 1 |
Aggarwal, NR; Chau, E; D'Alessio, FR; Florez, MA; Garibaldi, BT; Gibbs, KW; King, LS; Mandke, P; Mock, JR; Sidhaye, VK; Singer, BD; Tripathi, A; Yegnasubramanian, S | 1 |
Azab, M; Choy, G; Fang, F; Lyons, J; Matei, D; Miller, DF; Munck, J; Nephew, KP; Pawelczak, KS; Pilrose, J; Tang, J; Taverna, P; Turchi, JJ; VanderVere-Carozza, P; Wagner, M; Wang, Y | 1 |
Claret, FX; Wang, S; Yang, H; Zhang, R | 1 |
Hu, Z; Lian, F; Wang, Y; Xue, S; Yang, W; Zheng, H | 1 |
Liang, Y; Perez-Soler, R; Qiu, X; Sellers, RS; Zou, Y | 1 |
André, MC; Bühring, HJ; Ebinger, M; Handgretinger, R; Hartwig, UF; Herr, W; Kübler, A; Lang, P; Mezger, M; Münz, C; Oevermann, L; Witte, KE; Woiterski, J | 1 |
Abdolhosseini, M; Benakanakere, M; Finoti, LS; Hosur, K; Kinane, DF | 1 |
Arango-Gonzalez, B; Biel, M; Carell, T; Ekström, PA; Farinelli, P; Michalakis, S; Paquet-Durand, F; Perera, A; Trifunovic, D; Wagner, M; Zrenner, E | 1 |
Anthony, S; Corre, A; Gong, M; Liu, J; Rehan, VK; Sakurai, R | 1 |
Biankin, AV; Caldon, CE; Chang, DK; Colvin, EK; Henshall, SM; Mawson, A; Musgrove, EA; Pajic, M; Pinese, M; Scarlett, CJ; Susanto, JM; Sutherland, RL | 1 |
Gu, TX; Guan, XY; Jiang, DQ; Li, XY; Qi, X; Sun, XJ; Tang, R; Zhang, GW | 1 |
Cao, J; Chen, HQ; Han, F; Huang, C; Jiang, X; Li, YH; Liu, JY; Liu, WB; Liu, Y; Zhao, H | 1 |
Baugh, J; Corrigan, N; Glezeva, N; Horgan, S; Ledwidge, M; McDonald, K; Neary, R; Tea, I; Watson, CJ | 1 |
Gorman, S; Hart, PH; McGonigle, TA; Ng, RL; Scott, NM | 1 |
Antonios, JP; Everson, RG; Garrett, MC; Kruse, CA; Li, G; Li, N; Liau, LM; Lisiero, DN; Prins, RM; Scharnweber, R; Soto, H; Yong, WH | 1 |
Dong, Y; Ji, T; Liang, J; Ma, Z; Xiao, Y; Yin, G | 1 |
Chen, Y; Du, Q; Huang, Y; She, F; Wu, W | 1 |
Basavarajappa, BS; Nagre, NN; Shivakumar, M; Subbanna, S | 1 |
Bracci, L; Buccione, C; Businaro, L; D'Urso, MT; De Ninno, A; Gerardino, A; Lucarini, V; Macchia, D; Macchia, I; Mattei, F; Mattia, G; Mozetic, P; Parolini, I; Peschiaroli, F; Puglisi, R; Rainer, A; Rossi, A; Schiavoni, G; Sestili, P; Spada, M; Trombetta, M; Zanetti, C; Ziccheddu, G | 1 |
Cao, M; Hu, Y; Wu, H; Xue, X; Zhao, S | 1 |
Huang, X; Kong, G; Li, J; Li, Y; Liu, X; Wang, L; Wang, X; Wu, Y; Xu, H; Zhang, X; Zhang, Z; Zhu, W | 1 |
Li, H; Luan, P; Peng, W; Wang, K; Xu, Y; Zhang, P; Zhuang, J | 1 |
Han, Y; Han, YC; Jia, X; Li, F; Li, X; Ren, Z; Song, N; Xu, JX; Zhou, Y | 1 |
Ali, MW; Alqinyah, M; Cacan, E; Gao, M; Greer, SF; Hooks, SB; Maganti, N; Weng, HR; Yadav, R | 1 |
Huang, P; Jarpe, MB; Jones, SS; Min, C; Moore, N; Quayle, SN; Shearstone, JR; van Duzer, JH; Yang, M | 1 |
Balestrieri, C; Bertoni, F; Leoni, C; Montagner, S; Monticelli, S; Polletti, S; Rinaldi, A | 1 |
Fonte, E; Ghia, P; Muzio, M; Ntoufa, S; Papakonstantinou, N; Ranghetti, P; Scarfò, L; Stamatopoulos, K; Tocchetti, M; Veliz Rodriguez, T; Vilia, MG | 1 |
Bailey, N; Boon, K; Brass, DM; Garantziotis, S; Hollingsworth, JW; Li, Z; Maruoka, S; Potts, EN; Schwartz, DA; Tomfohr, J; Whitehead, G | 1 |
Chang, H; Chen, G; Feng, Y; Huang, H; Lin, F; Sun, A; Wang, Y; Wu, D | 1 |
Bologna, M; D'Alessandro, AM; Dolo, V; Festuccia, C; Gravina, GL; Millimaggi, D; Muzi, P; Ricevuto, E; Vicentini, C | 1 |
Fujiki, K; Kano, F; Murata, M; Shiota, K | 1 |
Chang, JK; Chang, LH; Chen, CH; Fu, YC; Ho, ML; Hung, SH; Lee, HY; Lin, YS; Wang, GJ; Wu, SC | 1 |
Baumann, S; Drost, AC; Feil, G; Kanz, L; Möhle, R; Schäfer, J; Sievert, KD; Stenzl, A; Weng, S | 1 |
Ao, L; Cao, J; Cui, ZH; Liu, JY; Liu, WB; Xiang, YL; Yuan, XY; Zhou, YH; Zhou, ZY | 1 |
Biojone, C; Gomes, MV; Guimarães, FS; Joca, SR; Sales, AJ; Terceti, MS | 1 |
Cao, G; Li, Y; Mu, Y; Zeng, Q | 1 |
Guo, QL; Huang, CS; Liu, C; Wang, Y; Yan, JQ; Zhu, XY; Zou, WY | 1 |
Chang, YL; Hong, TM; Jou, YS; Lin, JC; Lin, TC; Wu, CT; Wu, JY; Wu, YY; Yang, PC | 1 |
Kawamichi, Y; Saito, K; Umezawa, A | 1 |
Cao, F; Fan, W; Liang, D; Pei, X; Qin, X; Sun, D; Wang, S; Wang, Y; Xie, X | 1 |
Chang, C; Huang, CK; Jiang, Q; Lai, KP; Lee, SO; Li, L; Liang, L; Lin, TH; Luo, J; Ma, Z; Niu, Y; Tian, J; Yamashita, S; Yeh, CR; Yeh, S | 1 |
Ray, D; Richardson, B; Sawalha, AH; Yung, R | 1 |
Gallacher, J; Kalogerou, M; Sampson, JR; Shen, MH; Yang, J | 1 |
Bollag, G; Bornman, WG; Davies, MA; Dayyani, F; Desai, J; Gallick, GE; Gopal, YN; Jiang, ZQ; Kopetz, S; Lemos, R; Mao, M; Mariadason, JM; Mills, GB; Powis, G; Tang, XM; Tian, F; Tsao, CC; Wistuba, II | 1 |
Batte, K; Cantemir-Stone, CZ; Dakhlallah, D; Hitchcock, CL; Marsh, CB; Mikhail, A; Nana-Sinkam, SP; Nuovo, G; Piper, MG; Wang, Y; Wright, VP; Yan, P | 1 |
Bartoli, A; Delfino, DV; Di Ianni, M; Fetriconi, I; Fettucciari, K; Marconi, P; Rosati, E; Rossi, R; Tabilio, A | 1 |
Bae, YC; Baik, SY; Jung, JS; Kang, SK; Kim, HK; Lee, DH | 1 |
Adams, RJ; Atweh, GF; DeSimone, J; Fabry, ME; Fathallah, H; Nagel, RL; Saunthararajah, Y; Weinberg, RS | 1 |
Ray, D; Richardson, B; Yung, R | 1 |
Alleman, WG; Aprelikova, ON; Chandramouli, GV; Linehan, WM; Mendoza, A; Rodgers, C; Rogers, C; Sopko, NA; Tabios, RL; Torres-Cabala, C; Vasselli, JR | 1 |
Momparler, RL | 1 |
Chan, J; Fisk, NM; Gavina, M; Kennea, N; Mehmet, H; Morgan, JE; O'Donoghue, K; Stewart, H; Torrente, Y; Watt, DJ | 1 |
Haider, HKh | 1 |
Alexeeva, IV; Dyachenko, NS; Nosach, LN; Palchikovskaya, LI; Povnitsa, OY; Slita, AV; Sukhinin, VP; Zarubalev, VV; Zhovnovataya, VL | 1 |
Day, ML; Gschwend, JE; Kuefer, R; McCabe, MT; Wojno, KJ; Zorn, CS | 1 |
Doskocil, J; Rada, B | 1 |
DeSimone, J; Heller, P | 1 |
Benfield, JR; Hammond, WG | 1 |
Hoyt, PR; Popp, D; Saavedra, HI; Stambrook, PJ; Wang, TH; Yang, WK | 1 |
Erf, GF; Smyth, JR; Sreekumar, GP | 1 |
Baylin, SB; Belinsky, SA; Herman, JG; Middleton, SK; Nikula, KJ; Palmisano, WA; Swafford, DS; Tesfaigzi, J | 1 |
Ambady, S; Ponce de Leon, FA; Smyth, JR; Sreekumar, GP | 1 |
Hatta, T; Matsumoto, A; Moriyama, K; Otani, H | 1 |
Benedict, WF; Khwaja, TA | 1 |
Matsuda, M | 1 |
Glynn, JP; Goldberg, AI; Goldin, A; Kende, M; Mantel, N | 1 |
7 review(s) available for azacitidine and Disease Models, Animal
Article | Year |
---|---|
[Cell fusion as a key mechanism for cell-based therapy towards Duchenne muscular dystrophy].
Topics: Animals; Azacitidine; Cell Differentiation; Cell Fusion; Cell Transplantation; Cell- and Tissue-Based Therapy; Disease Models, Animal; Dystrophin; Endometrium; Female; Humans; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Placenta; Pregnancy; Regenerative Medicine | 2012 |
Hemoglobinopathies.
Topics: Animals; Azacitidine; Butyrates; Cerebral Hemorrhage; Decitabine; Disease Models, Animal; DNA Methylation; Globins; Hemoglobinopathies; Humans; Hydroxyurea; Mice; Stroke | 2003 |
Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).
Topics: Alleles; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cellular Senescence; Clinical Trials as Topic; Decitabine; Disease Models, Animal; DNA; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Gene Silencing; Genes, Tumor Suppressor; Humans; Models, Biological; Models, Chemical; Neoplasms; Phenotype; Phosphorylation; Prodrugs; S Phase; Time Factors | 2005 |
Bone marrow cells for cardiac regeneration and repair: current status and issues.
Topics: Animals; Antigens, CD34; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Movement; Cells, Cultured; Coronary Artery Bypass; Disease Models, Animal; Humans; Myocytes, Cardiac; Phenotype; Regeneration; Ventricular Dysfunction, Left | 2006 |
Azapyramidine nucleosides.
Topics: Animals; Antiviral Agents; Aza Compounds; Azacitidine; Azauridine; Chemical Phenomena; Chemistry; Disease Models, Animal; Embryo, Mammalian; Humans; Immunosuppressive Agents; Kinetics; Pyrimidine Nucleosides; Structure-Activity Relationship; Virus Replication | 1980 |
5-Azacytidine and fetal hemoglobin.
Topics: Adult; Anemia, Sickle Cell; Animals; Azacitidine; Carcinogens; Disease Models, Animal; DNA; Fetal Hemoglobin; Gene Expression Regulation; Humans; Male; Methylation; Middle Aged; Papio; Thalassemia | 1984 |
Hamster bronchial carcinogenesis induced by carcinogen-containing sustained release implants placed endobronchially: a clinically relevant model.
Topics: Animals; Azacitidine; Bronchial Neoplasms; Carcinogens; Cricetinae; Disease Models, Animal; Doxorubicin; Drug Implants; Humans; Mesocricetus; Mycobacterium bovis; Neoplasm Metastasis | 1993 |
1 trial(s) available for azacitidine and Disease Models, Animal
Article | Year |
---|---|
Increased IFNγ
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cytotoxicity, Immunologic; Decitabine; Disease Models, Animal; Disease Progression; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Female; Humans; Interferon-gamma; Lymphocyte Activation; Male; Mice; Neoplasms; Survival Analysis; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Th1 Cells; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
111 other study(ies) available for azacitidine and Disease Models, Animal
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis.
Topics: Animals; Azacitidine; Collagen; Disease Models, Animal; DNA; Enzyme Inhibitors; Methyltransferases; Mice; Osteogenesis; Osteogenesis Imperfecta; Phenotype | 2023 |
Loss of the dermis zinc transporter ZIP13 promotes the mildness of fibrosarcoma by inhibiting autophagy.
Topics: Animals; Autophagy; Azacitidine; Cation Transport Proteins; Cell Death; Cell Line; Dermis; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Ethylenediamines; Fibrosarcoma; Humans; Mice, Knockout; Microtubule-Associated Proteins; Zinc | 2019 |
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.
Topics: Adolescent; Animals; Antineoplastic Agents; Azacitidine; Bone Neoplasms; Carbon-Sulfur Lyases; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Heterografts; Humans; Male; Mice; Mice, Nude; Osteosarcoma; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Azoxymethane; bcl-Associated Death Protein; Carcinogenesis; Cell Line, Tumor; Colitis; Colon; Colonoscopy; Colorectal Neoplasms; Decitabine; Disease Models, Animal; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Intestinal Mucosa; Male; Mice; Molecular Targeted Therapy; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Up-Regulation | 2020 |
5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Leukemia, Myeloid, Acute; Mice; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2020 |
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Topics: Animals; Azacitidine; Benzamides; Cell Differentiation; Cell Movement; Chemotherapy, Adjuvant; Disease Models, Animal; Down-Regulation; Epigenesis, Genetic; Genetic Therapy; Mice; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neoplasms; Pyridines; Receptors, CCR2; Receptors, Interleukin-8B; Tumor Microenvironment | 2020 |
Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury.
Topics: Acute Lung Injury; Amitriptyline; Animals; Azacitidine; Calcitriol; Disease Models, Animal; Drug Repositioning; Female; Flavin-Adenine Dinucleotide; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL | 2020 |
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Disease Models, Animal; Female; Haplorhini; Humans; Infusions, Parenteral; Mice; Treatment Outcome; Uridine | 2020 |
5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Models, Animal; DNA Transposable Elements; Humans; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms | 2020 |
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Clonal Evolution; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Female; GTP Phosphohydrolases; Humans; Leukemia, Myelomonocytic, Chronic; Membrane Proteins; Mice; Mutation; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Receptor, Notch1; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2020 |
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Metabolic Networks and Pathways; Mice; Pyrimidines; Uridine Kinase | 2021 |
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Regulation; Genome-Wide Association Study; Humans; Leukemia, Myelomonocytic, Chronic; Mice; RNA, Messenger | 2021 |
Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice.
Topics: Animals; Azacitidine; Chemoradiotherapy; Disease Models, Animal; Drug Synergism; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Receptors, Cell Surface; Signal Transduction; Treatment Outcome | 2021 |
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Humans; Mice; Neoplastic Stem Cells; Ovarian Neoplasms; Peptide Nucleic Acids; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2021 |
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
Topics: Albuminuria; Animals; Azacitidine; Binding Sites; Cell Line; Cell Movement; Cell Proliferation; Cytoprotection; Decitabine; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Male; Mice, Inbred C57BL; Podocytes; Promoter Regions, Genetic; RNA Interference; Sp1 Transcription Factor; Time Factors; Transcription Factor RelA; Transfection | 2017 |
Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Benzamides; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class II; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Ovarian Neoplasms; Panobinostat; Pyridines; RNA, Messenger; Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Topics: Adult; Aged; Animals; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; CpG Islands; Decitabine; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Heterografts; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Prognosis; Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 2017 |
DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line; Cisplatin; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Epigenesis, Genetic; Gene Knockdown Techniques; Genome; Humans; Interferon Regulatory Factors; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Rats; Sequence Analysis, DNA | 2017 |
5-Aza-2'-deoxycytidine protects against emphysema in mice via suppressing p16
Topics: Animals; Azacitidine; Cells, Cultured; Cigarette Smoking; Cyclin-Dependent Kinase Inhibitor p16; Cytoprotection; Decitabine; Disease Models, Animal; Down-Regulation; Endothelial Progenitor Cells; Lung; Male; Mice, Inbred C57BL; Pulmonary Emphysema; Signal Transduction; Smoke | 2017 |
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Topics: Animals; Antineoplastic Agents, Immunological; Azacitidine; Cell Line, Tumor; Disease Models, Animal; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Immunomodulation; Interferon Type I; Mice; Ovarian Neoplasms; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus.
Topics: Animals; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; CpG Islands; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genetic Loci; Humans; Mice; MicroRNAs; Mutation; Neoplasm Invasiveness; Pancreatic Neoplasms; RNA, Messenger; Survival Analysis; Tumor Suppressor Protein p53 | 2018 |
Effect of Inhibition of DNA Methylation Combined with Task-Specific Training on Chronic Stroke Recovery.
Topics: Animals; Axons; Azacitidine; Brain-Derived Neurotrophic Factor; Decitabine; Disease Models, Animal; DNA Methylation; Exercise; Gene Expression Regulation; Humans; Male; Neuronal Plasticity; Rats; Stroke; Stroke Rehabilitation; Task Performance and Analysis | 2018 |
Precision DNA demethylation ameliorates disease in lupus-prone mice.
Topics: Animals; Azacitidine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Epigenesis, Genetic; Female; Humans; Immunoconjugates; Lupus Erythematosus, Systemic; Mice; Mice, Transgenic; Nanoconjugates; Treatment Outcome | 2018 |
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Topics: Animals; Antineoplastic Agents, Immunological; Azacitidine; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Disease Models, Animal; DNA Methylation; Down-Regulation; Humans; Immunity, Cellular; Leukemia, Myeloid, Acute; Mice, Inbred C57BL; Neoplasm Transplantation; Programmed Cell Death 1 Receptor; Retroviridae; Tumor Microenvironment; Virus Activation | 2019 |
Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Azacitidine; B-Lymphocytes; Chromatin Immunoprecipitation; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Flow Cytometry; Gene Silencing; Mice | 2019 |
DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cystadenocarcinoma, Serous; Disease Models, Animal; Eflornithine; Female; Immunity, Innate; Macrophages; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Polyamines; Tumor Cells, Cultured; Tumor Microenvironment | 2019 |
Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease.
Topics: Adolescent; Adoptive Transfer; Adult; Aged; Animals; Azacitidine; Cytosine; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Epigenesis, Genetic; Female; Gene Knockdown Techniques; Humans; Leukocytes, Mononuclear; Male; Mice; Middle Aged; Primary Cell Culture; Promoter Regions, Genetic; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation; Young Adult | 2019 |
Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model.
Topics: Animals; Azacitidine; Cochlea; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Ear, Inner; Enzyme Inhibitors; Furosemide; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Kanamycin; Mice; Regeneration | 2019 |
Chromatin remodeling--a novel strategy to control excessive alcohol drinking.
Topics: Acetylation; Alcoholism; Animals; Azacitidine; Behavior, Animal; Chromatin Assembly and Disassembly; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Histone Deacetylase Inhibitors; Histones; Humans; Mice; Rats | 2013 |
5-Aza-2'-deoxycytidine inhibited PDGF-induced rat airway smooth muscle cell phenotypic switching.
Topics: Airway Remodeling; Animals; Asthma; Azacitidine; Becaplermin; Biomarkers; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Techniques; Cytoskeleton; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Enzyme Inhibitors; Muscle Contraction; Muscle, Smooth; Phenotype; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Transcription, Genetic | 2013 |
Prevention of Helicobacter pylori-induced gastric cancers in gerbils by a DNA demethylating agent.
Topics: Adenocarcinoma; Animals; Azacitidine; Carcinogens; Decitabine; Disease Models, Animal; DNA Methylation; DNA-Cytosine Methylases; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Methylnitrosourea; Stomach Neoplasms | 2013 |
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Topics: Acetylation; Animals; Azacitidine; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Gene Knockdown Techniques; Gene Silencing; Histones; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Proteins; Promoter Regions, Genetic; Tumor Burden; Viral Core Proteins; Wnt Proteins; Xenograft Model Antitumor Assays | 2014 |
Prostaglandin E2 Promotes UV radiation-induced immune suppression through DNA hypermethylation.
Topics: Animals; Azacitidine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dermatitis, Contact; Dinoprostone; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Activation; Female; Gene Expression Regulation; Immune Tolerance; Male; Mice; Mice, Knockout; Radiation Tolerance; Receptors, Prostaglandin E, EP2 Subtype; Sp1 Transcription Factor; Sp3 Transcription Factor; Ultraviolet Rays | 2013 |
Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.
Topics: Animals; Asparaginase; Aspartate-Ammonia Ligase; Azacitidine; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Dogs; Drug Resistance, Neoplasm; Gene Expression; Humans; Lymphocytes; Lymphoma; Promoter Regions, Genetic; RNA, Messenger | 2014 |
DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cell Survival; CpG Islands; Disease Models, Animal; DNA Methylation; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Viral; Genetic Therapy; Genetic Vectors; Glioma; Herpesvirus 1, Human; Humans; Mice; Nestin; Oncolytic Virotherapy; Oncolytic Viruses; Promoter Regions, Genetic; Viral Proteins; Virus Replication; Xenograft Model Antitumor Assays | 2013 |
Protective effect of demethylation treatment on cigarette smoke extract-induced mouse emphysema model.
Topics: Animals; Apoptosis; Azacitidine; Decitabine; Disease Models, Animal; DNA-Binding Proteins; Electron Transport Complex IV; Emphysema; Lung; Male; Methylation; Mice; Mice, Inbred BALB C; Mitochondria; Mitochondrial Proteins; RNA, Messenger; Smoking; Transcription Factors | 2013 |
Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Azacitidine; Cell Line, Tumor; Dacarbazine; Decitabine; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Genomics; Humans; Lymphoma, Large B-Cell, Diffuse; Promoter Regions, Genetic; Temozolomide; Transcription Factors; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2014 |
5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Decitabine; Disease Models, Animal; Female; Flow Cytometry; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Photochemotherapy; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylation.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA Methylation; DNA Repair; Epigenesis, Genetic; Female; Gene Silencing; Humans; Mice; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Burden; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2014 |
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models.
Topics: Animals; Anti-Inflammatory Agents; Azacitidine; Cytokines; Decitabine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Mice; Multiple Sclerosis; T-Lymphocytes, Regulatory | 2014 |
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis.
Topics: Animals; Azacitidine; Blotting, Western; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dasatinib; Decitabine; Dioxygenases; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Enzyme Inhibitors; Esophagus; Gastric Mucosa; Humans; Mast Cells; Mastocytosis, Systemic; Mice, Knockout; Mice, Transgenic; Mutation, Missense; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA Interference; Skin; Stomach; Thiazoles | 2014 |
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Blotting, Western; Decitabine; Disease Models, Animal; DNA Damage; DNA Repair; Flow Cytometry; Fluorescent Antibody Technique; Homologous Recombination; Humans; Hydroxamic Acids; Mice; Mice, Inbred C57BL; Multiple Myeloma; Real-Time Polymerase Chain Reaction | 2014 |
Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Azacitidine; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Gene Expression Regulation; Homeodomain Proteins; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphoproteins; Plaque, Atherosclerotic; Promoter Regions, Genetic; Regional Blood Flow; RNA, Messenger; Stress, Mechanical; Transcription Factors | 2014 |
A recombinant reporter system for monitoring reactivation of an endogenously DNA hypermethylated gene.
Topics: Animals; Azacitidine; Cell Line, Tumor; CpG Islands; Disease Models, Animal; DNA Methylation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Order; Genes, Reporter; Green Fluorescent Proteins; Heterografts; Histone Deacetylase Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Recombinant Fusion Proteins; Transcriptional Activation | 2014 |
Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury.
Topics: Acetylation; Acute Lung Injury; Animals; Azacitidine; Blotting, Western; Capillary Permeability; Cell Proliferation; Cell Survival; Chromatin Immunoprecipitation; Decitabine; Disease Models, Animal; Drug Therapy, Combination; Endothelial Cells; Endotoxemia; Enzyme Inhibitors; Flow Cytometry; Fluorescent Antibody Technique; Hydroxamic Acids; In Situ Nick-End Labeling; Inflammation; Lung; Male; Methylation; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction | 2014 |
Demethylating drugs as novel analgesics for cancer pain.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Cytidine; Decitabine; Disease Models, Animal; DNA Methylation; Heterografts; Humans; Immunohistochemistry; In Situ Hybridization; Mice; Mouth Neoplasms; Neurons; Pain; Receptors, Opioid, mu; Reverse Transcriptase Polymerase Chain Reaction; Transduction, Genetic; Trigeminal Ganglion | 2014 |
Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain.
Topics: Animals; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Methylation; Mice; Morphine; Neuralgia; Neuroblastoma; Pain Measurement; Pain Threshold; Promoter Regions, Genetic; Receptors, Opioid, mu; Sensory Receptor Cells; Spinal Cord | 2014 |
Okadaic acid blocks the effects of 5-aza-2-deoxycytidine on consolidation, acquisition and retrieval of morphine-induced place preference in rats.
Topics: Animals; Azacitidine; CA1 Region, Hippocampal; Cerebral Cortex; Conditioning, Psychological; Decitabine; Disease Models, Animal; DNA Modification Methylases; Enzyme Inhibitors; Male; Memory; Morphine; Morphine Dependence; Narcotics; Okadaic Acid; Rats, Sprague-Dawley; Reward; Spatial Behavior | 2014 |
Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis.
Topics: Animals; Azacitidine; Chlorhexidine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Ethanol; Gene Expression Regulation; Male; Peritoneal Dialysis; Peritoneal Fibrosis; ras GTPase-Activating Proteins; Rats; Rats, Sprague-Dawley | 2014 |
Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet.
Topics: Animals; Anxiety; Azacitidine; Brain; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Decitabine; Diet, Fat-Restricted; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids, Omega-3; Female; Male; Maze Learning; Methylation; Mice; Neuroblastoma; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Transcription Factors | 2015 |
Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation.
Topics: Acute Lung Injury; Adoptive Transfer; Animals; Azacitidine; Cells, Cultured; Chemotaxis, Leukocyte; Decitabine; Disease Models, Animal; DNA Modification Methylases; Enzyme Inhibitors; Forkhead Transcription Factors; Homeodomain Proteins; Influenza A Virus, H1N1 Subtype; Lipopolysaccharides; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pneumonia; T-Lymphocytes, Regulatory; Time Factors | 2015 |
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cisplatin; Disease Models, Animal; DNA Adducts; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Ovarian Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation.
Topics: Animals; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Mice; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Nesprin-1 has key roles in the process of mesenchymal stem cell differentiation into cardiomyocyte-like cells in vivo and in vitro.
Topics: Actinin; Animals; Antigens, Surface; Azacitidine; Cell Culture Techniques; Cell Differentiation; Disease Models, Animal; Gene Expression Regulation; Immunophenotyping; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocytes, Cardiac; Nerve Tissue Proteins; Nuclear Proteins; Rats; RNA, Messenger; Troponin C | 2015 |
Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effects.
Topics: Administration, Inhalation; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Female; Lung Neoplasms; Male; Mice; Promoter Regions, Genetic; Transcriptional Activation; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2014 |
Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice.
Topics: Animals; Antineoplastic Agents; Azacitidine; Child; Cytokines; Cytotoxicity, Immunologic; Disease Models, Animal; DNA Methylation; Genotype; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Natural; Mice; Mice, Inbred NOD; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Receptors, KIR; Transplantation, Heterologous | 2014 |
TLR2 promoter hypermethylation creates innate immune dysbiosis.
Topics: Animals; Azacitidine; Bacteroidaceae Infections; Cell Culture Techniques; Chronic Periodontitis; CpG Islands; Decitabine; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Dysbiosis; Epigenesis, Genetic; Epithelial Cells; Genetic Predisposition to Disease; Gingiva; Host-Pathogen Interactions; Humans; Immunity, Innate; Inflammation Mediators; Interleukin-1beta; Mice; Mice, Inbred BALB C; Porphyromonas gingivalis; Toll-Like Receptor 2 | 2015 |
DNA methylation and differential gene regulation in photoreceptor cell death.
Topics: Animals; Apoptosis Regulatory Proteins; Azacitidine; Cell Death; Cells, Cultured; Chromatin; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Eye Proteins; Humans; In Situ Nick-End Labeling; Mice; Mutation; Nerve Tissue Proteins; Photoreceptor Cells, Vertebrate; Rats; Retinitis Pigmentosa; Tissue Culture Techniques | 2014 |
Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.
Topics: Animals; Azacitidine; Base Sequence; Cells, Cultured; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Fibroblasts; Fibronectins; Humans; Lung; Methyl-CpG-Binding Protein 2; Molecular Sequence Data; Nicotine; PPAR gamma; Pregnancy; Promoter Regions, Genetic; Pulmonary Alveoli; Rats; RNA, Messenger; Smoking; Up-Regulation | 2015 |
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo.
Topics: Animals; Antineoplastic Agents; Azacitidine; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Proliferation; Decitabine; Disease Models, Animal; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Vorinostat | 2015 |
Delayed enrichment for c-kit and inducing cardiac differentiation attenuated protective effects of BMSCs' transplantation in pig model of acute myocardial ischemia.
Topics: Animals; Azacitidine; Calcium Channels, L-Type; Cell Differentiation; Cells, Cultured; Coronary Circulation; Disease Models, Animal; Fibroblast Growth Factor 2; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Paracrine Communication; Phenotype; Proto-Oncogene Proteins c-kit; Regeneration; Swine; Swine, Miniature; Time Factors; Vascular Endothelial Growth Factor A; Ventricular Function, Left; von Willebrand Factor | 2015 |
TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.
Topics: Aged; Animals; Apoptosis; Azacitidine; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; CpG Islands; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Multivariate Analysis; Prognosis; Rats | 2015 |
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Topics: Actins; Animals; Azacitidine; Cardiomegaly; Carrier Proteins; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Male; Myocytes, Cardiac; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta1; Ventricular Remodeling | 2016 |
Reduced immune responses in chimeric mice engrafted with bone marrow cells from mice with airways inflammation.
Topics: Administration, Intranasal; Adoptive Transfer; Animals; Azacitidine; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Cell Count; Decitabine; Dendritic Cells; Disease Models, Animal; DNA Modification Methylases; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Immunoglobulin E; Immunoglobulin G; Inflammation; Lipopolysaccharides; Lymph Nodes; Mice, Inbred C57BL; Organic Chemicals; Ovalbumin; Radiation Chimera; Respiratory Hypersensitivity; Skin | 2015 |
Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Cell Line, Tumor; Decitabine; Disease Models, Animal; Glioblastoma; Humans; Immunotherapy, Adoptive; Mice; T-Lymphocytes | 2016 |
[5-aza-2'-deoxycytidine suppresses the growth of human lung adenocarcinoma cells in nude mouse xenograft models and its effect on methylation status and expression of TFPI-2 gene].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Proliferation; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Regulation, Neoplastic; Glycoproteins; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Nude; Random Allocation; RNA, Messenger | 2015 |
Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Decitabine; Disease Models, Animal; DNA Methylation; Female; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Male; Mice; Middle Aged; Promoter Regions, Genetic; Repressor Proteins | 2016 |
A single day of 5-azacytidine exposure during development induces neurodegeneration in neonatal mice and neurobehavioral deficits in adult mice.
Topics: Animals; Animals, Newborn; Azacitidine; Brain; Brain Diseases; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurodegenerative Diseases; Phosphopyruvate Hydratase; Receptor, Cannabinoid, CB1; Signal Transduction; Social Behavior | 2016 |
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.
Topics: Analysis of Variance; Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Interferon Type I; Melanoma; Mice; Mice, Inbred C57BL; Skin Neoplasms; Statistics, Nonparametric | 2017 |
5-aza-2'-deoxycytidine Inhibits the Proliferation of Lung Fibroblasts in Neonatal Rats Exposed to Hyperoxia.
Topics: Animals; Animals, Newborn; Azacitidine; Bronchopulmonary Dysplasia; Cell Proliferation; Decitabine; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Hyperoxia; Lung; Rats; Rats, Sprague-Dawley | 2017 |
Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Azacitidine; Decitabine; Disease Models, Animal; DNA Methylation; Glycocalyx; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Organ Size; Promoter Regions, Genetic; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins | 2016 |
The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Topics: 5-Methylcytosine; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azacitidine; Cell Dedifferentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Decitabine; Diet, High-Fat; Dioxygenases; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Signal Transduction; Time Factors; Trans-Activators; Vascular Remodeling | 2017 |
Changes in the methylation status of the Oct3/4, Nanog, and Sox2 promoters in stem cells during regeneration of rat tracheal epithelium after injury.
Topics: Animals; Azacitidine; Disease Models, Animal; DNA Methylation; Gene Expression; Immunohistochemistry; Nanog Homeobox Protein; Octamer Transcription Factor-3; Promoter Regions, Genetic; Rats; Regeneration; Respiratory Mucosa; SOXB1 Transcription Factors; Stem Cells; Trachea; Wound Healing | 2017 |
Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity.
Topics: Acetylation; Animals; Azacitidine; Cell Line; Chemokine CXCL2; Disease Models, Animal; Gene Silencing; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Lysophospholipids; Methyltransferases; Mice, Inbred C57BL; Microglia; Promoter Regions, Genetic; Receptors, G-Protein-Coupled; RGS Proteins; RNA, Messenger; Signal Transduction; Sphingosine; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2017 |
Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
Topics: Animals; Antineoplastic Agents; Azacitidine; Biomarkers; Bone Marrow Cells; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Female; GATA2 Transcription Factor; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Targeted Therapy; Xenograft Model Antitumor Assays | 2017 |
Topics: Animals; Azacitidine; Cell Degranulation; Cell Proliferation; Cells, Cultured; Decitabine; Dermatitis, Contact; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epigenesis, Genetic; Female; Fluorescent Antibody Technique; Immunoglobulin E; Interleukin-3; Mast Cells; Mastocytosis, Systemic; Mice; Mice, Knockout; Mutation; Oxazolone; Passive Cutaneous Anaphylaxis; ras GTPase-Activating Proteins; RNA Interference; RNA, Small Interfering | 2017 |
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Disease Models, Animal; DNA Methylation; Humans; Inflammation; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Receptors, Interleukin-1 | 2017 |
In utero supplementation with methyl donors enhances allergic airway disease in mice.
Topics: Animals; Asthma; Azacitidine; Cytokines; Dietary Supplements; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Phenotype; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Reproducibility of Results; Spleen | 2008 |
Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Azacitidine; Base Sequence; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Neoplasm Proteins; Oxides; RNA, Messenger; Transcription, Genetic; Xenograft Model Antitumor Assays | 2009 |
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Proliferation; Cisplatin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Docetaxel; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays | 2009 |
Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Azacitidine; Cell Proliferation; Chromatin Immunoprecipitation; Diabetes Mellitus; Dietary Fats; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Gene Expression; Intra-Abdominal Fat; Male; Mice; Molecular Sequence Data; NIH 3T3 Cells; Obesity; PPAR gamma; Promoter Regions, Genetic; RNA, Messenger; Sequence Alignment; Sequence Analysis, DNA; Subcutaneous Fat, Abdominal | 2009 |
Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
Topics: Adult; Animals; Azacitidine; Cartilage, Articular; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chondrocytes; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Glycosaminoglycans; Humans; Injections, Intra-Articular; Male; Middle Aged; Osteoarthritis; Papain; Parathyroid Hormone; Rats; Rats, Sprague-Dawley | 2009 |
In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair.
Topics: Animals; Azacitidine; Cell Differentiation; Disease Models, Animal; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Muscle Development; Rats; Rats, Nude; Urethral Diseases; Urinary Incontinence | 2009 |
Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
Topics: Animals; Azacitidine; Cadherins; Cell Adhesion; Cell Adhesion Molecules; Cell Transformation, Neoplastic; Decitabine; Diethylnitrosamine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Enzyme Inhibitors; Female; Gene Silencing; Immunoglobulins; Lung Neoplasms; Male; Methylcholanthrene; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-3; Up-Regulation | 2011 |
Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors.
Topics: Animals; Antidepressive Agents; Azacitidine; Behavior, Animal; Brain-Derived Neurotrophic Factor; Decitabine; Depression; Disease Models, Animal; DNA Methylation; Hindlimb Suspension; Hippocampus; Imipramine; Male; Mice; Rats; Swimming | 2011 |
Transplantation of induced bone marrow mesenchymal stem cells improves the cardiac function of rabbits with dilated cardiomyopathy via upregulation of vascular endothelial growth factor and its receptors.
Topics: Animals; Azacitidine; Blood Pressure; Bone Marrow Cells; Bone Marrow Transplantation; Cardiomyopathy, Dilated; Disease Models, Animal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rabbits; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury.
Topics: Analysis of Variance; Animals; Azacitidine; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation; Injections, Spinal; Male; Methyl-CpG-Binding Protein 2; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2011 |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Animals; Antigens, Neoplasm; Azacitidine; Base Sequence; Cell Adhesion Molecules; Cell Line, Tumor; Decitabine; Disease Models, Animal; Epigenesis, Genetic; Female; Gene Expression; Gene Expression Regulation; Gene Silencing; Histocytochemistry; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mice; Middle Aged; Models, Biological; Molecular Sequence Data; Receptor, IGF Type 1; Signal Transduction | 2012 |
Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
Topics: Animals; Azacitidine; Bone Marrow Cells; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Female; Hemodynamics; Hepatocyte Growth Factor; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Neovascularization, Physiologic; Rats; Rats, Wistar; Transfection; Ventricular Remodeling | 2012 |
New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.
Topics: Animals; Azacitidine; Curcumin; Decitabine; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplastic Stem Cells; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Murine models of lupus induced by hypomethylated T cells (DNA hypomethylation and lupus…).
Topics: Adoptive Transfer; Animals; Antibodies, Antinuclear; Azacitidine; Disease Models, Animal; DNA Methylation; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice; T-Lymphocytes | 2012 |
Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
Topics: Animals; Azacitidine; Blotting, Western; Catecholamine Plasma Membrane Transport Proteins; Decitabine; Disease Models, Animal; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Hypoglycemic Agents; Immunohistochemistry; Kidney; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Mice, Knockout; Multiprotein Complexes; Organic Cation Transport Proteins; Organic Cation Transporter 2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2013 |
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Indoles; Methylation; Mice; Mitogen-Activated Protein Kinases; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Sulfonamides; Vemurafenib | 2013 |
Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
Topics: Animals; Azacitidine; Cells, Cultured; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenomics; Fibroblasts; Gene Expression; Humans; Idiopathic Pulmonary Fibrosis; Mice; Mice, Inbred C57BL; MicroRNAs; Real-Time Polymerase Chain Reaction; Repressor Proteins; RNA, Long Noncoding | 2013 |
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells.
Topics: Animals; Azacitidine; beta-Galactosidase; Cell Differentiation; Clone Cells; Disease Models, Animal; Enzyme Inhibitors; Gene Silencing; Genetic Therapy; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; In Vitro Techniques; Mice; Rats; Simplexvirus; Thymidine Kinase; Transcriptional Activation; Transduction, Genetic; Transgenes; U937 Cells | 2003 |
Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats.
Topics: Adenoviridae; Adipose Tissue; Animals; Antigens, Differentiation; Azacitidine; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Movement; Cell Survival; Cells, Cultured; Disease Models, Animal; Graft Survival; Humans; Immunohistochemistry; Lateral Ventricles; Male; Neurons; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stromal Cells; Treatment Outcome | 2003 |
Murine models of lupus induced by hypomethylated T cells.
Topics: Adoptive Transfer; Animals; Antibodies, Antinuclear; Autoimmunity; Azacitidine; CD4-Positive T-Lymphocytes; Cell Line; Disease Models, Animal; DNA Methylation; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice; Mice, Inbred AKR; Mice, Inbred DBA | 2004 |
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
Topics: Adenocarcinoma, Clear Cell; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cytidine; Decitabine; Disease Models, Animal; DNA Methylation; Gene Silencing; Humans; Kidney Neoplasms; Mice; Pyrimidine Nucleosides; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2004 |
Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration.
Topics: Adult; Animals; Azacitidine; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Fetal Blood; Fetal Stem Cells; Galectin 1; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred mdx; Mice, Knockout; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Regeneration; Transplantation, Heterologous | 2006 |
Effect of 6-azacytidine on the course of experimental adenoviral infection in newborn Syrian hamsters.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Animals, Newborn; Antiviral Agents; Azacitidine; Cricetinae; Disease Models, Animal; Mesocricetus; Spleen | 2007 |
5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azacitidine; Castration; Combined Modality Therapy; Decitabine; Disease Models, Animal; Male; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Prostatic Neoplasms | 2007 |
Interleukin-3 increases the incidence of 5-azacytidine-induced thymic lymphomas in pBOR-Il-3 mice.
Topics: Animals; Azacitidine; Carcinogens; CD3 Complex; CD4 Antigens; CD8 Antigens; Disease Models, Animal; Female; Gene Rearrangement, T-Lymphocyte; Incidence; Interleukin-3; Male; Mice; Mice, Transgenic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thymus Neoplasms | 1996 |
5-azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo.
Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Chickens; Disease Models, Animal; Erythrocyte Count; Feathers; Incidence; Leukocyte Count; Lymphocyte Activation; Lymphoid Tissue; Organ Size; Vitiligo | 1996 |
Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
Topics: Amino Acid Sequence; Animals; Azacitidine; Base Sequence; Carrier Proteins; Cloning, Molecular; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; Disease Models, Animal; DNA Methylation; Exons; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Molecular Sequence Data; Proteins; Rats; Rats, Inbred F344; Sequence Analysis, DNA; Sequence Deletion; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Tumor Suppressor Protein p14ARF | 1997 |
Analysis of the effect of endogenous viral genes in the Smyth line chicken model for autoimmune vitiligo.
Topics: Animals; Autoimmune Diseases; Azacitidine; Blotting, Northern; Chickens; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Disease Models, Animal; DNA; DNA Fingerprinting; DNA Methylation; Endogenous Retroviruses; Female; Fibroblasts; Genes, Viral; In Situ Hybridization, Fluorescence; Male; Pedigree; Polymorphism, Restriction Fragment Length; RNA Viruses; RNA, Viral; Vitiligo | 2000 |
Sequential observations of exencephaly and subsequent morphological changes by mouse exo utero development system: analysis of the mechanism of transformation from exencephaly to anencephaly.
Topics: Abnormalities, Drug-Induced; Anencephaly; Animals; Azacitidine; Brain; Disease Models, Animal; Female; Male; Mice; Mice, Inbred ICR; Morphogenesis; Pregnancy | 2002 |
A new hamster fibrosarcoma model for in vitro/in vivo evaluation of cancer chemotherapeutic agents.
Topics: Ancitabine; Animals; Antineoplastic Agents; Azacitidine; Cell Division; Cell Line; Cells, Cultured; Clone Cells; Cricetinae; Cytarabine; Disease Models, Animal; Drug Therapy, Combination; Female; Fibrosarcoma; Mesocricetus; Sarcoma, Experimental | 1976 |
Comparison of the incidence of 5-azacytidine-induced exencephaly between MT/HokIdr and Slc:ICR mice.
Topics: Anencephaly; Animals; Azacitidine; Brain; Disease Models, Animal; Embryonic and Fetal Development; Female; Fetal Death; In Vitro Techniques; Mice; Mice, Inbred ICR; Neural Tube Defects; Pregnancy; Species Specificity | 1990 |
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Female; Imidazoles; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Oxazines; Prednisone; Remission, Spontaneous; Time Factors; Triazenes; Vincristine | 1972 |